AhmanF.R., WooL., GuevaraA., NaglerR.: The growth of benign prostatic hypertrophy in semisolid agar culture. J. Urol, 138, 154 (1986).
2.
AlbertsD.S., SalmonS.E., ChenH.S.G, SurwitE.A., SoehnlenB., YoungL., MoonT.E.: In vitro donogenic assay for predicting response of ovarian cancer to chemotherapy. Lancet, 16; 340 (1980).
3.
AllegraS.R., FanningJ.P., StrekerJ.F., CorveseN.M.: Cytologic diagnosis of occult in situ carcinoma of the urinary system. Acta cytol., 10; 340 (1966).
4.
AllegraS.R., BroderickP.A., CorveseN.L.: Cytologic and histogenic observation in well differentiated transitional cell carcinoma of blander. J. Urol., 107; 777 (1972).
5.
AlpiG., BarberiG., FidenzoniL., GrecaP., LentiniM., MiccolisS., NatiliG., ProsperiF.: I tumori della via escretrice superiore (pelvi ed ureteri). Atti S.I.U. XLVIII Congresso, Milano 1975.
6.
AnselmoG., RizzottiA., FeuciE., BassiE., MaccatrozzoL.: Multiple simultaneous bilateral tumours of the renal pelvis. Brit. J. Urol., 60; 312 (1978).
7.
AnselmoG., RizzottiA., GramegnaV., FornasieroG.: Sulle neoplasie uroteliali delle alte vie escretrici. Atti VIII Convegno Assodazione Triveneta Urologia. Castelfranco Veneto, Treviso, 27 aprile 1980. Urologia, 47; Suppl. 36 (1980).
8.
ArgerP.H., MulgherC.B., PollackH.M.: Ultrasonic assessment of renal transitional cell carcinoma: preliminary report. Amer. J. Roetgenol., 132; 407 (1979).
9.
AsoY., OhtawaraY., SuzukiK., TajimaA., FujitaK.: Usefulness of fiberoptic pyelouretoscope in the diagnosis of the upper urinary tract lesions. Urol. Intern., 39; 353 (1984).
10.
AtkinN.B., BakerM.C.: I (12P): specific chromosomal marker in seminoma and malignant teratoma of the testis? Cancer Gen. Cytogen., 10; 199 (1983).
11.
BabaianR.J., JohnsonD.E., ChanR.C.: Combination nephroureterectomy and postoperative radiotherapy for infiltrative ureteral carcinoma. Intern. J. Radioter. Oncol. Biol. Phys., 6; 1229 (1980).
12.
BabaianR.J., JohnsonD.E.: Primary carcinoma of the ureter. J. Urol., 123; 357 (1980).
13.
Balaban-MalenbaumG., GilbertF., NicholsW.W., HillR., ShieldsJ., MeadowsA.T.: A delected chromosome n. 13 in human retinoblastoma cells: relevance to tumor genesis. Cancer Ge. Cytogen., 3; 243 (1981).
14.
BaronR.L., McClennanB.L., LeeJ.K.: Computed tomography of transitional cell carcinoma of the renal pelvis and ureter. Radiology, 144; 125 (1982).
BatataM.A., WithmoreW.F., HilarisB.J.: Primary carcinoma of the ureter: a prognostic study. Cancer, 35; 1626 (1975).
17.
BazeedM.A., ScharfeT., BechtE., AlkenP., ThuroffJ.W.: Local excision of urothelial cancer of the upper urinary tract. Eur. Urol., 12; 89 (1986).
18.
BenningtonJ.L., BeckwithJ.B.: Tumors of the kidney, renal pelvis and ureter. Atlas of Tumor Pathology, 12; (1975).
19.
BergkvistA., LjunquistA., MobergerG.: Classification of tumours based on the cellular pattern. Acta Chir. Scand., 130; 371 (1965).
20.
BergmanS., JavadpourN.: The cell surface antigen A, B or O (H) as an indicator of malignant potential in stage A bladder carcinoma: preliminary report. J. Urol., 119; (1978).
21.
BertelsenC.A., SondakV.K., MannB.D., KornE.L., KernD.H.: Chemosensitivity testing of human solid tumors. A review of 1582 assay with 258 clinical correlations. Cancer, 53; 1240 (1984).
22.
Beyer BoonM.E., CuypersL.H., De VoogtH.J., BrusseeJ.A.: Cytological changes due to urinary calculi: a consideration of the relationship between calculi and the development of urothelial carcinoma. Brit. J. Urol., 50; 81 (1978).
23.
BishopJ.M.: Enemies within the genesis of retroviral oncogenes. Cell., 23; 5–6 (1981).
24.
BonnM.E., De VoogtH.J., Van der VeldeE.A., BrusseA.M., SchabergA.: The efficacy of urinary cytology. The detection of urothelial tumors. Urol. Res., 6; 3 (1978).
25.
BorgstromE., WahrenB.: Clinical significance of A, B, H isoantigen deletion of urothelial cells in bladder carcinoma. Cancer, 58; 2428 (1986).
26.
BottiC., OlmiR., FiloniA., OleariG., NasiG.: Trattamento percutaneo dei tumori uroteliali delle alte vie escretrici. Urologia, 55; 37 (1988).
27.
BradleyC.E., ReichertC.M., BrennanM.F., Von HoffD.D.: Direction cloning of parathyroid hiperplasia cells in soft agar culture. Cancer Res., 40; 3691 (1980).
28.
BrannanW.: Accuracy of cytologic examination of urinary sediment in the detection of urothelial tumors. J. Urol., 109; 483 (1973).
29.
BuickR.N., ChangL.J., MessnerH.A., CurtisJ.E., McCullochE.A.: Self-renewal capacity of leukemic blast progenitor cells. Cancer Res., 41; 4849 (1981).
30.
BuickR.N., MackillopW.J.: Measurement of self-renewal in culture of clonogenic cell from human ovarian carcinoma. Brit. J. Cancer, 44; 349 (1981).
31.
CarneyD.N., GaidarA.F., BunnP.A., GuccionJ.G.: Demonstration of the stem cell natura of clonogenic tumor cells fron lung cancer patients. Stem. Cell., 1; 149 (1981).
32.
CharterS.C., CoxR., WickhamJ.E.A.: Complications associated with ureteroscopy. Brit. J. Urol., 58; 625 (1986).
33.
ChagantiR.S.K., JhanwarS.C.: Chromosomal mechanisms of cancer etiology. In: ChagantiR.S.K., GermanJ. (eds.): genetics in clinical oncology.Oxford University Press, New York1985.
34.
ChinJ.L., HubenR., NavaE., RustumY., GrecoJ.: Flow cytometric analysis of DNA content in human bladder tumours and irrigation fluids. Cancer, 56; 1677 (1985).
35.
ClaymanR.V., GarskeG.L., LangeP.H.: Total nephroureterectomy with ureteral intussusception and transurethral ureteral detachment and pull-through. Urology, 21; 482 (1983).
36.
Cosciani-CunicoS., CozzoliA., SimeoneC.: L'esame istologico estemporaneo dell'uretere prevescicale in corso di cistectomia: provvedimento utile?Urologia, 53; 392 (1986).
37.
CrabbeJ.G.S., CresdeeW., ScottT.S., WilliamsM.H.: The cytological diagnosis of bladder tumor amongst dyestuff workers. Brit. J. Indust. Med., 13; 270 (1956).
38.
CukierJ., AbourachidH., PascalB., SoeurJ.P., MerimskyE.: Tumeurs de la vie excrétrice haute. Une série de 130 observations. J. d'Urol., 87; 57 (1981).
39.
CullenT.H., PophamR.R., VossH.J.: An evaluation of routine cytological examination of the urine. Brit. J. Urol., 39; 615 (1967).
40.
CullenT.H., PophamR., VossH.J.: Urine cytology and primary carcinoma of the renal pelvis and ureter. Austr. New Zeal. J. Surg., 41; 230 (1972).
41.
CummingsK.B.: Nephroureterectomy: rationale in the management of transitional cell carcinoma of the upper urinary tract. Urol. Clin. N. Amer., 7; 569 (1980).
42.
Dalla PalmaL., BazzocchiM., Pozzi-MucelliR.S., RossiM., StaculF., AgostiniR., MaffessantiM.: The role of ultrasonography in the diagnosis of tumors of the renal pelvis. Europ. J. Radiol., 4; 156 (1984).
43.
DavidsonI., KovarichS., LiL.Y.: Isoantigens A.B. and H in benign and malignant lesions of the cervis. Arch. Pathol., 87; 306 (1969).
44.
DavidsonI., LiL.Y.: Loss of isoantigens A. B. and H. in carcinoma of the lung. Amer. J. Pathol., 57; 307 (1969).
45.
De BackerE., KaeckenbeeckB., Van CrombruggeY., Schmitz-GiannassoD.: Tumeurs de la voie excrétrice urinaire supérieure. Incidence pronostique de l'anatomopathologie e de la thérapeutique. In: Tumeurs de la voie excrétrice haute. CukierJ. (ed.). Masson, Paris1981.
46.
De MartinvilleB., GiacaloneJ., ShihC., WeinbergR.A., FranckeU.: Oncogene from human bladder carcinoma is located on the short arm of chromosome 11. Science, 219; 498 (1983).
47.
DittrichCh., SchmidbauerCh.P., HavelecL., LenzhoferR., BreyerSt., PorpaczyP., MoserK.: Assessment of the human tumor cloning assay for urologic malignancies with special emphasis on bladder cancer. Oncology, 43; 40 (1986).
48.
DonohueR.E.: Radical nephroureterectomy for carcinoma of the renal pelvis and uteter. In: Genitourinary cancer surgery.CrawfordE.D., BordenT.A. (eds.) Lea & Febiger, Philadelphia1982.
49.
DufourB.: Les obstructions de l'uretère lombo-iliaque à l'exclusion des tumeur urétérales.Masson, Paris1973.
50.
DurieB.G., YoungA.L., SalmonS.E.: Human myeloma in vitro colony growth: interrelationships between drug sensitivity, cell kinetics and patient survival duration. Blood, 61; 929 (1983).
51.
EkmanP., HusainI., SharmN.D., Al FaqihS.R.: Transurethral ureteroscopy. Safety guide wire as an aid to a more aggressive approach. Brit. J. Urol., 60; 23 (1987).
52.
El-BolkainyM.N.: Cytology of bladder carcinoma. J. Urol., 124; 20 (1980).
53.
ElsdaleT., BardJ.: Collagen substrata for studies on cell behaviour. J. Cell. Biol., 54; 626 (1972).
EspostiP.L., MobergerG., ZajicekJ.: The cytologic diagnosis of transitional cell tumors of the urinary bladder and its histologic basis. Acta Cytol., 14; 145 (1970).
56.
EspostiP.L., ZajicekJ.: Grading of transitional cell neoplasms of the urinary bladder from smears of bladder washing. Acta Cytol., 16; 529 (1972).
57.
FalorW., WardR.: Prognosis in early carcinoma of bladder based on chromosomes analysis. J. Urol., 130; 44 (1984).
58.
FalorW.H., WardR.M.: Prognosis in early carcinoma of the bladder based on chromosomal analysis. J. Urol., 119; 44 (1978).
59.
FarrowG.M.: Pathologist's role in bladder cancer. Semin. Oncol., 16; 128 (1979).
60.
FidlerI.J.: Recent concepts of cancer metastases and their implications for therapy. Cancer Treat. Rep., 68; 193 (1984).
GatewoodO.M., GoldmanS.M., MarshallF.: Computerized tomography in the diagnosis of transitional cell carcinoma of the kidney. J. Urol., 127; 876 (1982).
71.
GeerdsenJ.: Tumours of the renal pelvis and ureter. Scand. J. Urol. Nephrol., 13; 287 (1979).
72.
GibasZ., ProutG.R.Jr., ConnollyJ.G., PontesJ.E., SandbergA.A.: Nonrandom chromosomal changes in transitional cell carcinoma of the bladder. Cancer Res., 44; 1257 (1984).
73.
GilchrestB.A., NemoreR.E., MaciagT.: Growth of human keranocytes of fibronectin. Coated plates. Cell. Biol. Int. Rep., 4; 1009 (1980).
GraceD.A., TaylorW.N., TaylorJ.N., WinterC.C.: Carcinoma of the renal pelvis: a 15 years review. J. Urol., 98; 566 (1967).
83.
Granberg-OhmanI., TribukaitB., WijkstromH.: Cytogenetic analysis of 62 transitional cell bladder carcinomas. Cancer Genet. Cytogenet., 11; 69 (1984).
84.
GrassetD., GuiterJ.: Les tumeurs multifocales de la voie excréto-urinaire haute. In: Tumeurs de la voie excrétrice haute, sous la direction de J. Cukier.Masson, Paris1973.
85.
HadjissotiriouG.G., GreenD.K., SmithG., McIntyreM.A., HargreaveT.B., ChisholmG.D.: Bladder cancer flow cytometry profiles in relation to histological grade and stage. Brit. J. Urol., 60; 239 (1987).
86.
HamburgherA.W., SalmonS.E.: Primary bioassay of human tumor stem cells. Science, 197; 461 (1977).
87.
HeneyN.M., NocksB.N., DalyJ.J., BlitzerP.H., ParkhurstE.C.: Prognostic factors in carcinoma of the ureter. J. Urol., 125; 632 (1981).
88.
HeneyN.M., SzyfelbeinM., DalyJ., ProutG.R., BredinH.C.: Positive urinary cytology in patients evident tumor. J. Urol., 117; 223 (1977).
89.
HenrikssonC., NilsonA.E., PetterssonS.: Widespread urothelial tumor treated with bilateral nephroureterectomy, cystectomy, autotransplantation of one kidney and pelvioileocutaneostomy. J. Urol., 131; 555 (1984).
90.
HeppnerG.H.: Tumor heterogeneity. Cancer Res., 44; 2259 (1984).
91.
HerrH.W.: Durable response of a carcinoma in situ of the renal pelvis to topical B.C.G. J. Urol., 134; 531 (1985).
HuffmanJ.L., BagleyD.H., LyonE.S., MorseM.J., HerrH.W., WhitmoreW.F.: Endoscopic diagnosis and treatment of upper tract urothelial tumors. Cancer, 55; 1422 (1985).
94.
HunterT.S.: The proteins of oncogenes. Sci. Amer., 251; 70–79 (1984).
95.
InfantolinoD., Dalla PalmaP., MazzoleniG.P., ClemenP., VenzaE.: Correlazioni tra grading citologico ed istologico nei carcinomi transizionali della vescica. Riv. Medica Trentina, 25; 140 (1987).
96.
JohanssonS., AngervallL., BengtssonV., WahiqbistL.: A clinicopathologic and prognostic studies of epithelial tumors of the renal pelvis. Cancer, 32; 1376 (1976).
97.
JohnsonD.E., BabaianR.G.: Conservative surgical management for non invasive distal ureteral carcinoma. Urology, 13; 365 (1979).
JohnsonJ.D., LammD.L.: Prediction of bladder tumor invasion with the mixed cell agglutination test. J. Urol., 123; 25 (1980).
100.
JohnsonW.D.: Cytopathological correlations in tumors of the urinary bladder. Cancer, 17; 867 (1964).
101.
JuhlB.R., HartzenS., HainauB.: Lewis A antigen in transitional cell tumours of the urinary bladder. Cancer, 58; 222 (1986).
102.
KagawaS., TakigawaH., GhazizadehM., KurokawaK.: Immunohistological detection of T antigen and ABH blood group antigens in upper urinary tract tumours. Brit. J. Urol., 57; 386 (1985).
103.
KernW.H.: The cytology of transitional cell carcinoma of the urinary bladder. Acta Cytol., 19; 420 (1978).
104.
KimballF.N., FerrisH.W.: Papillomatous tumors of the renal pelvis associated with similar tumors of the ureter and bladder. J. Urol., 31; 257 (1934).
105.
KirkelsW.J., PelgrimO.E., DebruyneF.M.J., VooiysG.P., HermanC.J.: Soft agar culture of human transitional cell carcinoma colonies from urine. A.M.J. Clin. Pathol., 78; 690 (1982).
106.
KirlaliZ., DeaneR.F., KyleK.F., GrahamA.G.: Blood groups and transitional cell carcinoma of the upper urinary tract. Eur. Urol., 14; 22 (1988).
107.
KivettE.J., SchnitzerB., KerenD.F., FlintA., HudsonJ.L., McClatcheyK.D.: Application of flow cytometry to diagnostic pathology. Lab. Invest., 50; 115 (1983).
108.
KlotzL.H.: Management of urothelial carcinoma of the upper tracts. A.U.A. Study Program, 7; 4 (1987).
109.
KossL.G.: Diagnostic cytology.Lippincot CompanyPhiladelphia. Vol. II, 3a ediz., 1979.
110.
KovnatA., BuickR.N., ConnollyJ.G., JewettM.A., KeresteciA.G., TannockI.F.: Comparision of growth of human bladder cancer in tissue culture or as xenografts with clinical and pathological characteristics. Cancer Res., 44; 2530 (1984).
111.
LangeP.H., LimasC., FraleyE.E.: Tissue blood group antigens and prognosis in low stage transitional cell carcinoma of the bladder. J. Urol., 119; 52 (1978).
112.
LathamH.S., KayS.: Malignant tumours of the renal pelvis. Surg., Gynec. & Obst., 138; 613 (1974).
LeibovitzA.: Development of tumor cell lines. Cancer Genet. Cytogenet., 19; 11 (1986).
115.
LeistenscheiderW., NagelR.: Lavage cytology of the renal pelvis and ureter with special reference to tumors. J. Urol., 124; 597 (1980).
116.
LieberM.M.: Soft agar colony formation assay for in vitro chemotherapy sensitivity testing of human renal cell carcinoma: Mayo clinic experience. J. Urol., 131; 391 (1984).
117.
LiebermanN., CabaudP.G., HammF.C.: Value of the urine sediment smear for the diagnosis of cancer. J. Urol., 89; 514 (1963).
118.
LoweP.P., RoylanceJ.: Transitional cell carcinoma of the kidney. Clin. Radiol., 27; 503 (1976).
Martinez-PiñeiroJ.A., PertusaC., TorronterasJ., ArmeroA.H.: Tumeurs urothéliales du haut appareil urinaire apparaissant après le traitement d'un carcinome de la vessie. In: Tumeurs de la voie excrétrice haute, sous la direction de J. Cukier.Masson, Paris1981.
121.
MattoxD., Von HoffD.D.: In vitro stem cell assay in head and neck squamous carcinoma. Amer. J. Surg., 140; 527 (1980).
122.
MazemanE.: Tumours of the upper urinary tract, calyces, renal pelvis and ureter. Eur. Urol., 2; 120 (1976).
123.
McAllisterR.M., ReedG.: Colonical growth in agar of cells derived from neoplastic and non-neoplastic tissues of children. Ped. Res., 39; 1133 (1979).
124.
McCarronJ.P., MillsC., VaughanE.D.: Tumors of the renal pelvis and ureter: current concepts and management. Seminars in Urology, 1; 1 (1983).
125.
McCarronJ.P., ChaskoS.B., GrayG.F.: Systematic mapping of nephroureterectomy specimens removed for urothelial cancer: pathological findings and clinical correlations. J. Urol., 128; 248 (1982).
126.
McDonaldM.W., ZinckeH.: Urothelial tumors of the upper urinary tract. In: De KernionJ.B., PaulsonD.F.: Genitourinary cancer management.Lea & Febiger, Philadelphia1987.
127.
MelamedM.R., KossL.G., RicciA., WhitmoreW.F.: Cyto-histological observation on developing carcinoma of the urinary bladder man. Cancer, 13; 67 (1960).
128.
MelamedM.R.: Flow cytometry of the urinary bladder. Urol. Clin. N. Amer., 11; 599 (1984).
129.
MelicowM.: The urothelium: a battleground for oncogenesis. J. Urol., 120; 43 (1978).
130.
MillsC., VaughanD.E.: Carcinoma of the ureter: natural history, management and 5-years survival. J. Urol., 129; 275 (1983).
131.
MincioneG.P., GrechiG., SansottaG.: Urinary cytology in the diagnosis of epithelial bladder tumors. Pathologica, 75; 665 (1983).
132.
MiskowiakJ.: Stripping of the distal ureter after nephrectomy for pelvis papilloma. Scand. J. Urol. Nephrol., 20; 285 (1986).
133.
MukamelE., NissenkornI., GlanzE., VilcouskyE., ServadioC.: Upper tract tumours in patients with vesico-ureteral reflux and recurrent bladder tumours. Eur. Urol., 11; 6 (1985).
134.
MulhollandS.G., ArgerP.H., GoldbergB.B., PollackH.M.: Ultrasonic differentiation of renal pelvic filling defect. J. Urol., 122; 14 (1979).
135.
MurphyD.M., ZinckeH., FurlowW.L.: Management of high grade transitional cell cancer of the upper urinary tract. J. Urol., 125; 25 (1981).
136.
MurphyD.M., ZinckeH., FurlowW.I.: Primary grade I transitional cell carcinoma of the renal pelvis and ureter. J. Urol., 123; 629 (1980).
MurphyW.M.: Current topics in the pathology of bladder cancer. Pathol. Ann., 18; parte 2 (1983).
139.
NakagamiY., HorioY., SaitoT.: A case of transitional cell carcinoma of renal pelvis in a child. Jap. J. Clin. Urol., 22; 523 (1968).
140.
NiellH.B., SolowayM.S.: Use of the tumor colony assay in the evaluation of patients with bladder cancer. Brit. J. Urol., 55; 271 (1983).
141.
NiellH.B., SolowayM.S., NissenkornI.: The clonogenic growth of cells derived from bladder barbotage in patients with transitional cell carcinoma of the bladder: a preliminary report. J. Urol., 127; 668 (1982).
PaganoF.: Conservative treatment of lower ureteral tumor: modified ureteroneocystostomy for upper urinary tract endoscopic control. J. Urol., 132; 555 (1984).
144.
PapadopoulosI., FiggeM., WeissbachL., MerkelK.H.H.: Diagnosis of urothelial tumor by ureterorenoscopy. Eur. Urol., 13; 196 (1987):
145.
Patch, Riches, Higgins: cit ati da E. Mazeman: Tumeurs de la voie excrétrice haute, p. 3. Masson, Paris 1981.
146.
PauwelsR.P., SmeetsW.W., GeraedtsJ.P., DebruyneF.M.: Cytogenetic analysis in urothelial cell carcinoma. J. Urol., 137; 210 (1987).
147.
PavelicK., BalbulM.A., SlocumH.K., PavelicZ.P., RustumY.M., NiedbalaM.J., BernackR.J.: Growth of human urological tumors on extracellular matrix as a model for the vitro cultivation of primary human tumor explants. Cancer Res., 46; 3653 (1986).
148.
PavelicZ.P., SlocumK.H., RustumY.M.: Growth of cell colonies in soft agar from biopsies of different human solid tumor. Cancer Res., 40; 4151 (1980).
PetkovicS.D.: Conservation of the kidney in operations for tumors of the renal pelvis and calyces: a report of 26 cases. Brit. J. Urol., 44; 1 (1972).
154.
PetterssonS., BryngerH., HenricssonC., JohanssonS.L., NilsonA.E., RanchT.: Treatment of urothelial tumors of the upper urinary tract by nephroureterectomy, renal autotransplantation, and pyelocystostomy. Cancer, 54; 379 (1984).
155.
PetterssonS., BryngerH., JohanssonS.: Extracorporeal surgery and autotransplantation for carcinoma of the pelvis and ureter. Scand. J. Urol. Nephrol., 13; 89 (1979).
156.
PetterssonS.: Treatment of urothelial tumors of the upper urinary tract by nephroureterectomy renal autotransplantation and pyelocystostomy. Cancer, 54; 379 (1984).
RaflaS.: Tumors of the upper urothelium. Amer. J. Roentgenol., 123; 540 (1975).
159.
ReidL.M., RojkindM.: New techniques for culturing differentiated cells: reconstituted basement membrane raft. In: JakobyW.B., PastanI.H. (eds): methods in enzymology. Vol. LVII; p. 263: Cell. culture. Academic Press, New York1979.
160.
ReitelmanC., SawczukI.S., OlssonC.A., PuchnerP.J., Benson, MitchellC.: Prognostic variables in patients with transitional cell carcinoma of the renal pelvis and proximal ureter. J. Urol., 138; 1144 (1987).
161.
RichieJ.P., BluteR.D., WaismanJ.: Immunologic indicators of prognosis in bladder cancer: the importance of cell surface antigens. J. Urol., 123; 22 (1980).
162.
RifeC.C., FarrowG.M., UtzD.C.: Urine cytology of transitional cell neoplasm. Urol. Clin. N. Amer., 6; 599 (1979).
163.
RolandS.I., MarshallV.F.: The reability of the Papanicolaou technique when cancer cells are found in the urine. Surg. Gynec. & Obst., 104; 41 (1957).
164.
RongG.H., GrimmE., SindelarW.F.: An enzymatic method for the consistent production of monodispersed viable cell suspension from human solid tumor. J. Surg. Oncol., 28; 131 (1985).
165.
RosenfieldA.T., TaylorJ.K., DembnerA.G., JacobsonP.: Ultrasound of renal sinus: a new observation. Amer. J. Radiol., 133; 441 (1979).
166.
RowleyJ.D.: A new consistent chromosomial abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and giemsa staining. Nature, 243; 290 (1973).
167.
RubbenH., BubenzerJ., BokenkampK., LutzeyerW., RathertP.: Grading of transitional cell tumors of the urinary tract by urinary cytology. Urol. Res., 7; (1979).
168.
SalmonS.E.: Human tumor clonogenic assay: growth conditions and applications. Cancer Genet. Cytogenet., 19; 21 (1986).
169.
SamdbergA.A.: Chromosome markers and progression in bladder cancer. Cancer Res., 37; 1718 (1977).
170.
SandbachJ., Von HoffD.D., ClarkG., CruzA., ObrienM.: Direct cloning of human breast cancer in soft agar culture. Cancer, 50; 1315 (1982).
171.
SarosdyM.F., LammD.L., RadwinH.M., Von HoffD.D.: Clonogenic assay and in vitro chemosensitivity testing of human urologic malignancies. Cancer, 50; 1332 (1982).
172.
SchadeR.O., Serck-Hansenna, SwinneyJ.: Morphological changes in the ureter in cases of bladder carcinoma. Cancer, 27; 1267 (1971).
SchadeR.O.K.: Some observation on the pathology and natural history of urothelial neoplams. Beitr. Pathol., 145; 325 (1972).
175.
SchlagP., FlentjeD.: Chemosensitivity testing of neoplasms using the soft agar colony assay. Cancer Treat. Rev., 11; 131 (1984).
176.
SelbyP., BuickR.N., TannockI.: A critical apparaisal of the <human tumor stem cell assay>. N. Eng. J. Med., 308; 129 (1983).
177.
ShenoyU.A., TomasV.C., SchumannBerry: Reability of urinary cytodiagnosis in urothelial neoplasms. Cancer, 56; 2041 (1985).
178.
SherwoodT.: Upper urinary tract tumours following on bladder carcinoma: natural history of urothelial neoplastic disease. Brit. J. Radiol., 44; 137 (1971).
179.
ShoemakerR.H., FilippesWolpert-De, KernD.H., LieberM.M., MakuchR.W., MelnickN.R., MillerW.T., SalmonS.E., SimonR.M., VendittiJ.M., Von HoffD.D.: Application of human tumor colony forming assay to new drug screening. Cancer Res., 45; 2145 (1985).
180.
SilverbergE.: Cancer statistics. Cancer, 34; 7 (1984).
181.
SingletaryS.E., UmbachG.E., SpitzerG., DrevinkoB., TomasovicB., AjaniJ., HugV., BlumenscheinG.: The human tumor stem cell assay rivisited. Intern J. Cell. Clon., 3; 116 (1985).
182.
SkinnerD.G.: Technique of nephroureterectomy with regional lymph node dissection. Urol. Clin. N. Amer., 5; 253 (1978).
183.
SlamonD.J., De KernionK.B., VermaI.M., ClineM.J.: Expression of cellular oncogenes in human malignancies. Science, 224; 256 (1984).
184.
SlaterR.M., De KrakerJ.: Chromosome N. 11 and wilms’ tumor. Cancer Gen. Cytogen., 5; 237 (1982).
185.
SmithA.D., OrihuelaE., CrowleyA.R.: Percutaneous management of renal pelvic tumors: a treatment option in selected cases. J. Urol., 137; 852 (1987).
186.
SmithC.: Carcinoma in situ. Hum. Pathol., 9; 373 (1978).
187.
Solé BalcellsF., ZungriE.: Le tumeur de la voie cxcréto-urinaire haute. In: Tumeurs de la voie excrétrice haute, sous la direction de J. Cukier.Masson, Paris1981.
188.
SotoE.A., FreiedellG.H., TiltmanA.J.: Bladder cancer as seen in giant histologic section. Cancer, 39; 447 (1977).
189.
SouthcottR.D.C.: Conservative surgery for ureteric tumours. Brit. J. Urol., 58; 371 (1986).
190.
SpremulliE.N., DexterD.L.: Human tumor cell heterogeneity and metastasis. Clin. Oncol., 1; 496 (1983).
191.
StanisicT.H., BuickR.N.: An in vitro clonal assay for bladder cancer: clinical correlation with the status of the urothelium in 33 patients. J. Urol., 124; 30 (1980).
192.
StanisicT.H., BuickR.N., TrentJ.M., FryS.E., SalmomS.E.: An in vitro clonal assay for bladder cancer: studies of the biologic potential of the urothelium and determination of in vitro sensitivity tocytotoxic agent. J. Surg. Oncol., 18; 67 (1981).
193.
StanisicT.H., OwensR., GragamA.R.: Use of clonal assay in determination of urothelial drug sensitivity in carcinoma in situ of the bladder: clinical correlations in 5 patients. J. Urol., 129; 949 (1983).
194.
StreemS.B., PontesE.J.: Percutaneous management of upper tract transitional cell carcinoma. J. Urol., 133; 773 (1986).
195.
StreemS.B., PontesJ.E., NovickA.C., MontieJ.E.: Ureteropyeloscopy in the evaluation of upper tract filling defects. J. Urol., 136; 383 (1986).
196.
StrongD.W., PearseH.D.: Recurrent urothelial tumors following surgery for transitional cell carcinoma of the upper urinary tract. Cancer, 38; 2178 (1976).
197.
SummersJ.L., FalorW.H., WardR.: A 10 year analysis of chromosomes in non invasive papillary carcinoma of the bladder. J. Urol., 125; 177 (1981).
198.
SutherlandC.M., MatherF.J., CarterR.D., CeriseE.J., KrementzE.T.: Breast cancer as analyzed by the human tumor stem cell assay. Surgery, 94; 370 (1983).
199.
TaylorW.N.: Tumors of the kidney pelvis. J. Urol., 82; 452 (1959).
200.
ThomsonS.P., MeyskensF.L.: Method of measurement of self-renewal capacity of clonogenic cell from biopsies of metastatic human malignant melanoma. Cancer Res., 42; 4606 (1982).
201.
ThuroffJ.W., HutschenreiterG., FrohnebergD., HohenfellnerR.: Transplantation of a free peritoneal patch in surgery of the renal pelvis and ureter. Eur. Urol., 7; 304 (1981).
202.
TomeraK.M., LearyF.J., ZinckeH.: Pyeloscopy in urothelial tumors. J. Urol., 127; 1088 (1982).
203.
TweddaleD.N.: Urinary cytology.Little Brown Co., Boston1977.
204.
UmikerW.: Accuracy of cytologic diagnosis of cancer of the urinary tract. Acta Cytol., 8; 126 (1964).
205.
UtzD.C., FarrowG.M., RifeC.C., SeguraC.C., ZinckeJ.W.: Carcinoma in situ of the bladder. Cancer, 45; 1842 (1980).
206.
VarmusH.E.: The molecular genetics of cellular oncogenes. Ann. Rev. Genet., 18; 553 (1984).
207.
VestS.A.: Conservative surgery in certain benign tumors of the ureter. J. Urol., 53; 97 (1945).
208.
VivilleC.h., FornoffH., BellocqJ.P.: Intérêt de la otologic urinaire dans la récerche et la surveillance des tumeurs de l'appareil urinaire. J. d'Urol., 92; 275 (1986).
209.
Von HoffD.D., SandbachJ., OsborneC.K.: Potential and problems with growth of breast cancer in a human tumor colony system breast. Cancer Res. Treat., 1; 141 (1981).
210.
WallaceD.M.: Tumours of the ureter. Proc. Roy. Soc. Med., 62; 94 (1969).
211.
WallaceD.M.A., WallaceD.M., WhitfieldN.H., HendryW.F., WickhamJ.E.A.: The late result of conservative surgery for upper tract urothelial carcinomas. Brit. J. Urol., 53; 537 (1981).
212.
WalzerY., SolowayM.S.: Should the follow-up patient with bladder cancer include routine excretory urogram? J. Urol., 130; 672 (1983).
213.
WeinbergR.A., KingstonR.F., BaldwinA.S., SharpP.A.: Transcription control by oncogenes. Cell., 41; 3–5 (1985).
214.
WerthD.D., WeigwlJ.W., MebustW.K.: Primary neoplasms of the ureter. J. Urol., 125; 628 (1981).
215.
WiggishoffC., McDonaldJ.H.: Urinary exfoliative cytoly in tumors of the kidney and ureter. J. Urol., 102; 170 (1969).
216.
WilliamsR.D., HricakH.: Magnetic resonance imaging in urology. J. Urol., 132; 641 (1984).
217.
WolfH., HjgaardK.: Prognostic factors in local surgical treatment of invasive bladder cancer with special reference to the presence of urothelial dysplasia. Cancer, 51; 1710 (1983).
218.
WoodhouseC.R.J., KelletM.J., BloomJ.G.: Percutaneus renal surgery and local radiotherapy in the management of renal pelvic transitional cell carcinoma. Brit. J. Urol., 58; 245 (1986).
219.
YokozekiJ.: A case of malignant tumor of the left renal pelvis in a 12 year-old girl. Jap. J. Urol., 44; 375 (1953).
220.
YunisJ.J.: New chromosome techniques in the study of human neoplasia. Hum. Pathol., 12; 540 (1981).
221.
ZechL., HaglundU., NilssonK., KleinG.: Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with burkitt, and non-burkitt lymphomas. Intern. J. Cancer., 17; 47 (1976).
222.
ZiegelbaumM., NovickA.C., StreemA.B., MontieJ.E., PontesJ.E., StraffonR.A.: Conservative surgery for transitional cell carcinoma of renal pelvis. J. Urol., 138; 1146 (1987).
223.
ZinckeH., NevesR.J.: Feasibility of conservative surgery for transitional cell carcinoma of the upper urinary tract. Urol. Clin. N. Amer., 11; 717 (1984).
224.
ZinckeH., PeterJ., Garbeff, BeahrsR.J.: Upper urinary tract transitional cell cancer after radical cystectomy for bladder cancer. J. Urol., 133; 50 (1984).
225.
ZinckeH., AguilloJ., FarrowG.M.: Utz D., Khan A.: Significance of urinary cytology in the early detection of transitional cell cancer of the upper urinary tract. J. Urol., 116; 781 (1976).